Arjen Joosse

Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis

Arjen Joosse, Esther de Vries, Renate Eckel et al. · Journal of Investigative Dermatology · 2010 · 264 citations

Medicine, Dermatology, Oncology +16

Superior Outcome of Women With Stage I/II Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase III Trials

Arjen Joosse, Sandra Collette, Stefan Suciu et al. · Journal of Clinical Oncology · 2012 · 192 citations · Full text

Medicine, Dermatology, Oncology +16

Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials

Arjen Joosse, Sandra Collette, Stefan Suciu et al. · Journal of Clinical Oncology · 2013 · 191 citations

Medicine, Biostatistics, Oncology +17

Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study

E.R. Koomen, Arjen Joosse, Ron M. C. Herings et al. · Annals of Oncology · 2008 · 88 citations · Full text

Medicine, Dermatology, Oncology +14

Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients

Edwin A. Basak, Jan W.M. van der Meer, Daan P. Hurkmans et al. · Thyroid · 2020 · 88 citations

Life Sciences, Immunology, Oncology +17